Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (331-340 of 505) with videos related to

Pageof 51
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 12, 2026
Defining disease stability in COPD: Evidence from Phase 3 clinical trialsDave Singh, Rianne Stacey, David M G Halpin, et al.
Respiratory Research|June 8, 2019
Airway host-microbiome interactions in chronic obstructive pulmonary diseaseZhang Wang, Barbara Maschera, Simon Lea, et al.
Inflammopharmacology|April 20, 2022
COPD lung studies of Nrf2 expression and the effects of Nrf2 activatorsJian Li, James Baker, Andrew Higham, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 6, 2017
Ampicillin resistance in <i>Haemophilus influenzae</i> from COPD patients in the UKSatyanarayana Maddi, Umme Kolsum, Sarah Jackson, et al.
Respiratory Research|November 2, 2020
Bacteria and sputum inflammatory cell counts; a COPD cohort analysisAugusta S Beech, Simon Lea, Umme Kolsum, et al.
Respiratory Research|August 11, 2019
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPDDave Singh, Kai Michael Beeh, Brendan Colgan, et al.
The European Respiratory Journal|April 18, 2024
The association of blood eosinophil counts and FEV<sub>1</sub> decline: a cohort studyYun Soo Hong, Hye Yun Park, Seungho Ryu, et al.
Respiratory Research|September 18, 2020
Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trialsDave Singh, Jadwiga A Wedzicha, Salman Siddiqui, et al.
Plos One|February 10, 2021
Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarkerBert Rutten, Simon Young, Magdalena Rhedin, et al.
British Journal of Clinical Pharmacology|December 27, 2018
Comparison of the effect of beclometasone/formoterol in asthma patients after methacholine-induced bronchoconstriction: A noninferiority study using metered dose vs. dry powder inhalerDave Singh, Frans van den Berg, Brian Leaker, et al.
Pageof 51

Showing results (331-340 of 505) with videos related to

Sort By:
Pageof 51
American Journal of Respiratory and Critical Care Medicine|June 12, 2026
Defining disease stability in COPD: Evidence from Phase 3 clinical trialsDave Singh, Rianne Stacey, David M G Halpin, et al.
Respiratory Research|June 8, 2019
Airway host-microbiome interactions in chronic obstructive pulmonary diseaseZhang Wang, Barbara Maschera, Simon Lea, et al.
Inflammopharmacology|April 20, 2022
COPD lung studies of Nrf2 expression and the effects of Nrf2 activatorsJian Li, James Baker, Andrew Higham, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 6, 2017
Ampicillin resistance in <i>Haemophilus influenzae</i> from COPD patients in the UKSatyanarayana Maddi, Umme Kolsum, Sarah Jackson, et al.
Respiratory Research|November 2, 2020
Bacteria and sputum inflammatory cell counts; a COPD cohort analysisAugusta S Beech, Simon Lea, Umme Kolsum, et al.
Respiratory Research|August 11, 2019
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPDDave Singh, Kai Michael Beeh, Brendan Colgan, et al.
The European Respiratory Journal|April 18, 2024
The association of blood eosinophil counts and FEV<sub>1</sub> decline: a cohort studyYun Soo Hong, Hye Yun Park, Seungho Ryu, et al.
Respiratory Research|September 18, 2020
Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trialsDave Singh, Jadwiga A Wedzicha, Salman Siddiqui, et al.
Plos One|February 10, 2021
Eosinophil-derived neurotoxin: A biologically and analytically attractive asthma biomarkerBert Rutten, Simon Young, Magdalena Rhedin, et al.
British Journal of Clinical Pharmacology|December 27, 2018
Comparison of the effect of beclometasone/formoterol in asthma patients after methacholine-induced bronchoconstriction: A noninferiority study using metered dose vs. dry powder inhalerDave Singh, Frans van den Berg, Brian Leaker, et al.
Pageof 51